EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

GENETIC AND MOLECULAR BIOMARKERS OF AUTOIMMUNE DISEASES: FROM IMMUNE DYSREGULATION TO PERSONALIZED THERAPY

Aziz Kazbichevich Akhmedov, Ramzan Khasainovich Tavsultanov, Anzhela Aslanbekovna Inazhaeva, Lyudmila Alekseevna Dorodnitskaya, Makhosheva Karina Ruslanovna, Patimat Magomedzagirovna Magomedova, Isropil Borisovich Evloev, Kardangusheva Bela Kazbekovna, Ovsepyan Sofya Georgievna

Genetics and Molecular Research · 15.07.2026

DOI: 10.4238/4s2wwg74 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics and Molecular Research, online erschienen am 15.07.2026. Verfasst von Aziz Kazbichevich Akhmedov und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune diseases are heterogeneous disorders caused by the interaction of inherited susceptibility, epigenetic remodeling, environmental exposure, and dysregulated innate and adaptive immunity. The rapid development of genome-wide association studies, next-generation sequencing, single-cell technologies, and high-throughput proteomics has expanded the spectrum of candidate biomarkers that can be used for risk prediction, early diagnosis, assessment of disease activity, prognosis, and treatment selection. This narrative review summarizes the clinical significance of HLA alleles, non-HLA susceptibility genes, polygenic risk scores, DNA methylation patterns, non-coding RNAs, autoantibodies, cytokines, complement components, and multi-omics signatures in major autoimmune diseases. Particular attention is given to the translation of biomarkers into personalized therapeutic strategies, including patient stratification for biologic agents, Janus kinase inhibitors, B-cell-targeted therapy, and cellular approaches. The main limitations remain population heterogeneity, insufficient external validation, pre-analytical variability, and the lack of standardized multi-marker panels. Integration of genetic, epigenetic, transcriptomic, proteomic, and clinical data is the most promising route toward reproducible biomarker systems and precision medicine in autoimmunity.

Zitieren

APA

Akhmedov, A. K., Tavsultanov, R. K., Inazhaeva, A. A., Dorodnitskaya, L. A., Ruslanovna, M. K., Magomedova, P. M., Evloev, I. B., Kazbekovna, K. B., & Georgievna, O. S. (2026). GENETIC AND MOLECULAR BIOMARKERS OF AUTOIMMUNE DISEASES: FROM IMMUNE DYSREGULATION TO PERSONALIZED THERAPY. Genetics and Molecular Research. https://doi.org/10.4238/4s2wwg74

Vancouver

Akhmedov AK, Tavsultanov RK, Inazhaeva AA, Dorodnitskaya LA, Ruslanovna MK, Magomedova PM, et al. GENETIC AND MOLECULAR BIOMARKERS OF AUTOIMMUNE DISEASES: FROM IMMUNE DYSREGULATION TO PERSONALIZED THERAPY. Genetics and Molecular Research. 2026. doi:10.4238/4s2wwg74

BibTeX
@article{Akhmedov2026,
  author = {Akhmedov, Aziz Kazbichevich and Tavsultanov, Ramzan Khasainovich and Inazhaeva, Anzhela Aslanbekovna and Dorodnitskaya, Lyudmila Alekseevna and Ruslanovna, Makhosheva Karina and Magomedova, Patimat Magomedzagirovna and Evloev, Isropil Borisovich and Kazbekovna, Kardangusheva Bela and Georgievna, Ovsepyan Sofya},
  title = {GENETIC AND MOLECULAR BIOMARKERS OF AUTOIMMUNE DISEASES: FROM IMMUNE DYSREGULATION TO PERSONALIZED THERAPY},
  journal = {Genetics and Molecular Research},
  year = {2026},
  doi = {10.4238/4s2wwg74}
}
Kostenlos starten →